GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Cortex Pharmaceuticals, Inc. (COR) [hlAlert]

Rating:
Buy COR
down 14.54 %

Cortex Pharmaceuticals, Inc. (COR) rated Buy with price target $65.50 by BB&T Capital Mkts

Posted on: Thursday,  Nov 12, 2015  11:25 AM ET by BB&T Capital Mkts

BB&T Capital Mkts rated Buy Cortex Pharmaceuticals, Inc. (NYSE: COR) on 11/12/2015, when the stock price was $57.00.
Since then, Cortex Pharmaceuticals, Inc. has lost 14.54% as of 01/13/2016's recent price of $48.71.
If you would have followed this BB&T Capital Mkts's recommendation on COR, you would have lost 14.54% of your investment in 62 days.

Cortex Pharmaceuticals, Inc. (Cortex) focuses on developing small molecule compounds that positively modulate AMPA-type glutamate receptors, a complex of proteins involved in the communication between nerve cells in the mammalian brain. These compounds, termed AMPAKINE compounds, enhance the activity of the AMPA receptor. The Company designs and develops these molecules as pharmaceuticals intended for the treatment of neurological and psychiatric diseases, and disorders that are known, or thought, to involve depressed functioning of pathways in the brain that use glutamate as a neurotransmitter. The Company?s clinical compound, CX717 is in Phase II clinical development. Diseases, such as alzheimer?s disease, mild cognitive impairment (MCI), attention deficit hyperactivity disorder (ADHD), schizophrenia, depression, respiratory depression caused by opiate analgesics, and possibly sleep apnea may benefit from treatment with AMPAKINE drugs.

BB&T Capital Markets is dedicated to delivering world-class corporate banking, investment banking, and capital markets solutions to commercial clients, corporate clients, and government entities. Our customer focus and team approach, combined with the fast-growing strength and national recognition of BB&T, equip us to build lasting relationships and contribute significantly to the long-term success of each client.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/12/2015 11:25 AM Buy
None
57.00 65.50
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy